Stock Snapshot
| Table Header | Table Header |
|---|---|
| Company | Dassault Aviation S.A. |
| Sector | Industry |
| Theme | Aerospace & Defense |
| Business Model | Development and distribution of medicines, medical technology, surgical systems, and innovative healthcare solutions worldwide. |
| ISIN | FR0014004L86 |
| Market Capitalization | approx. €23.1 billion |
| UMBRELLA Status | Watchlist |
Johnson & Johnson is today one of the world’s largest and most stable healthcare companies and is considered one of the most important global players in pharmaceuticals, medical technology, and healthcare innovation.
The company develops prescription drugs, surgical systems, orthopedic solutions, medical technology products, and innovative therapies in areas such as oncology, immunology, neuroscience, and cardiovascular diseases. Through its global market position and strong research base, Johnson & Johnson has one of the most diversified business models in the international healthcare sector.
The investment story is significantly driven by long-term structural growth drivers in the global healthcare market. The aging global population, rising healthcare expenditures, medical innovations, and the increasing demand for modern therapies and medical technology lead to steadily growing demand in the long term.
In contrast to cyclical industrial companies, Johnson & Johnson increasingly benefits from structural and defensive growth through:
- rising global healthcare expenditures
- demographic change and aging population
- innovations in pharmaceutical research
- growing demand for medical technology
- increasing importance of personalized medicine
- expansion of modern surgical technologies
- global expansion in the healthcare sector
- long-term stable demand for medical care
- strong market position and high brand recognition
→ Key variables: global healthcare demand + medical innovation + aging population.
